Company profile: iMedX
1.1 - Company Overview
Company description
- Provider of outsourced healthcare software and services to hospitals and physician practices in the U.S., including revenue cycle management, medical coding, code auditing, healthcare analytics, and medical transcription. Offers TurboScribe Enterprise to access and manage transcriptions online and provides transcription disaster recovery.
Products and services
- Healthcare Analytics: Data-driven platform that surfaces revenue cycle management insights and operational issues, enabling providers to identify and recover lost revenue across hospital and clinic operations
- Medical Coding: Standards-based service that converts healthcare diagnoses, procedures, and services into standardized medical codes to support billing workflows and regulatory compliance for hospitals and physician practices
- Revenue Cycle Management: Enterprise-grade service that manages providers’ billing and collections processes end-to-end, ensuring accurate and timely reimbursement for hospitals and physician practices
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to iMedX
Imbio
HQ: United States
Website
- Description: Provider of medical imaging software that saves lives and reduces costs, delivering automated CT analysis: Lung Texture Analysis to map and quantify lung textures for interstitial lung diseases and fibrotic conditions; Lung Density Analysis (Inspiration, Functional, Plus) for emphysema/COPD, air-trapping, consolidation and ground glass; RV/LV ratio analysis from CTPA; and Airway Analysis of lumen, diameters, wall thickness, and wall percentage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Imbio company profile →
Truepill
HQ: United States
Website
- Description: Provider of API-connected B2B healthcare infrastructure for pharmacy and telehealth, including a virtual pharmacy platform, nationwide pharmacy fulfillment to 50 states, patient services for prescription and insurance management, and RESTful APIs integrating provider networks for clinical, diagnosis, prescribing, and prescription management; serving D2C consumer brands, digital health companies, and healthcare organizations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Truepill company profile →
Acumyn
HQ: Canada
Website
- Description: Provider of web-based QA management software for radiotherapy departments. Its AQUA platform streamlines QA workflows by automating and standardizing QA protocols, reducing resources required to run tests, with out-of-the-box test protocols for TG142.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acumyn company profile →
Coriell Life Sciences
HQ: United States
Website
- Description: Provider of precision medicine solutions using pharmacogenomics, bioinformatics, and clinical decision support software. Offers turnkey genetic interpretation, reporting, and medication risk management for payers, pharmacists, providers, and patients. Products include Corigen Medication Safety Program, Pharmacogenomic Research Analysis Services, Return-to-Operations Program, GeneDose, and GeneDose LIVE.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Coriell Life Sciences company profile →
i-Human Patients
HQ: United States
Website
- Description: Provider of cloud-based, interactive medical education simulation solutions, including the i-Human Patients platform for virtual patient encounters and structured clinical cases across medical, physician assistant, and nursing programs (graduate and undergraduate), with over 350 cases and 230 avatars, Next Generation NCLEX-aligned cases, and OSCEs (12 cases) for formative learning and competency assessment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full i-Human Patients company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for iMedX
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to iMedX
2.2 - Growth funds investing in similar companies to iMedX
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for iMedX
4.2 - Public trading comparable groups for iMedX
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →